International Journal of Infectious Diseases
Volume 14, Issue 9 , Pages e781-e787 , September 2010

Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice

  • Gul Ahmad

      Affiliations

    • Department of Microbiology and Immunology, Texas Tech University Health Sciences Center, 3601 4th Street, Mail Stop 6591, Lubbock, TX 79430, USA
  • ,
  • Weidong Zhang

      Affiliations

    • Department of Microbiology and Immunology, Texas Tech University Health Sciences Center, 3601 4th Street, Mail Stop 6591, Lubbock, TX 79430, USA
  • ,
  • Workineh Torben

      Affiliations

    • Department of Microbiology and Immunology, Texas Tech University Health Sciences Center, 3601 4th Street, Mail Stop 6591, Lubbock, TX 79430, USA
  • ,
  • Zahid Noor

      Affiliations

    • Department of Microbiology and Immunology, Texas Tech University Health Sciences Center, 3601 4th Street, Mail Stop 6591, Lubbock, TX 79430, USA
  • ,
  • Afzal A. Siddiqui

      Affiliations

    • Department of Microbiology and Immunology, Texas Tech University Health Sciences Center, 3601 4th Street, Mail Stop 6591, Lubbock, TX 79430, USA
    • Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 806 743 2638; fax: +1 806 743 2334.

Received 9 November 2009 ,Accepted 27 February 2010.

  • Image Result

    Relative cytokine mRNA expression levels by splenocytes after 48h stimulation with recombinant Sm-p80 in vitro. The relative cytokine mRNA expression was calculated by comparing the differences in the

    Relative cytokine mRNA expression levels by splenocytes after 48h stimulation with recombinant Sm-p80 in vitro. The relative cytokine mRNA expression was calculated by comparing the differences in the message levels of the control group with the respective experimental group after standardization using glyceraldehyde 3-phosphate dehydrogenase (GAPDH); (A) ‘DNA prime–protein boost’ group; (B) ‘recombinant protein–R848’ group..

PII: S1201-9712(10)02403-3

doi: 10.1016/j.ijid.2010.02.2266

International Journal of Infectious Diseases
Volume 14, Issue 9 , Pages e781-e787 , September 2010